Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

52.51
Delayed Data
As of Feb 17
 -0.27 / -0.51%
Today’s Change
39.35
Today|||52-Week Range
56.50
-1.91%
Year-to-Date
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb 16 / Zacks.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More
Feb 15 / Zacks.com - Paid Partner Content
Zoetis Reports Earnings Beat, So Why Are Shares Plummeting?
Feb 16 / TheStreet.com - Paid Partner Content
Bill Ackman Buys Chipotle Mexican Grill, Sells Zoetis, Versum Materials
Feb 14 / GuruFocus News - Paid Partner Content
Bill Ackman Expands Chipotle Position, Cuts Zoetis
Feb 15 / GuruFocus News - Paid Partner Content
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary
Feb 14 / GuruFocus News - Paid Partner Content
Bill Ackman Swaps Pet Meds for Burritos
Feb 15 / TheStreet.com - Paid Partner Content
Use Pullback on Zoetis to Do Some Buying
Feb 13 / TheStreet.com - Paid Partner Content
Finish the Week with the Top Earnings Charts
Feb 15 / Zacks.com - Paid Partner Content
Will Zoetis (ZTS) Disappoint Estimates This Earnings Season?
Feb 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close52.78
Today’s open53.01
Day’s range52.32 - 53.52
Volume8,167,474
Average volume (3 months)3,529,078
Market cap$25.8B
Dividend yield0.80%
Data as of 4:01pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+13.88%
Revenue growth (last year)+2.58%
P/E ratio37.8
Price/Sales5.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.31+0.63%
INCYIncyte Corp+0.31+0.26%
ALXNAlexion Pharmaceutic...-1.57-1.20%
MYLMylan NV+0.05+0.12%
Data as of 4:01pm ET, 02/17/2017

Financials

Last reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts


Search for Jobs